THIS WEBSITE HAS BEEN PRODUCED BY SHIRE AND IS NOT INTENDED FOR RESIDENTS OF THE USA, IRELAND AND THE UK

Contact us

For more information on Replagal (Replagal product-related inquiries), please contact our Medical Information department. Please select the contact details for your region. We look forward to hearing from you.

Asia, Australia and New Zealand:
medinfoapac@shire.com

Latin America:
medinfolatam@shire.com

Canada:
medinfona@shire.com

European countries and Middle East and Africa:
medinfoemea@shire.com

*Pharmacovigilance:
globalpharmacovigilance@shire.com

World Map

*Product safety

Nothing is more important to us than the safety of the people who use our treatments. For that reason, we are constantly working to identify, understand, minimise and communicate any adverse effects associated with our medicines.

*Monitoring safety

Our Pharmacovigilance Department continually evaluates and monitors the safety of our treatments after they reach the marketplace. Adverse events are reported to relevant health authorities, and the information is used to continually update the risk/benefit profile of our medicines.

*Safety governance

From detailed risk management plans to periodic assessments and inspections made by major regulatory authorities, our robust safety governance process ensures we respond to safety issues quickly, appropriately, and in compliance with global legislation and regulations. To report suspected side effects for Shire products, please contact globalpharmacovigilance@shire.com. If you are a healthcare professional, you can contact Shire Medical Information by visiting www.shiremedinfo.com.